BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19028541)

  • 1. Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone.
    Yeh YW; Chen YC; Chen CK; Feng HM; Wang TY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):162-3. PubMed ID: 19028541
    [No Abstract]   [Full Text] [Related]  

  • 2. Ziprasidone-induced acute laryngeal dystonia.
    Duggal HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):970; author reply 971. PubMed ID: 17343967
    [No Abstract]   [Full Text] [Related]  

  • 3. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight Gain While Switching from Polypharmacy to Ziprasidone: A Case Report.
    Lee CP; Chen AP; Juang YY
    Clin Schizophr Relat Psychoses; 2015; 9(3):141-4. PubMed ID: 23644168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 6. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia.
    Ziegenbein M; Calliess IT
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):246-7. PubMed ID: 16720806
    [No Abstract]   [Full Text] [Related]  

  • 8. Cocaine use as a risk factor for ziprasidone-induced acute dystonia.
    Duggal HS
    Gen Hosp Psychiatry; 2007; 29(3):278-9. PubMed ID: 17484950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third degree heart block following intramuscular ziprasidone.
    Tambyraja R; Strawn JR
    Schizophr Res; 2011 Feb; 125(2-3):302-3. PubMed ID: 20692812
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute dystonia, akathisia, and parkinsonism induced by ziprasidone.
    Praharaj SK; Jana AK; Sarkhel S; Sinha VK
    Am J Ther; 2014; 21(2):e38-40. PubMed ID: 23698184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):108-9. PubMed ID: 18305296
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodological concerns in a trial of ziprasidone and olanzapine.
    Ross DE
    Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
    [No Abstract]   [Full Text] [Related]  

  • 13. An assessor-blinded, randomized comparison of efficacy and tolerability of switching from olanzapine to ziprasidone and the combination of both in schizophrenia spectrum disorders.
    Wang HH; Cai M; Wang HN; Chen YC; Zhang RG; Wang Y; McAlonan GM; Bai YH; Wu WJ; Guo L; Zhang YH; Tan QR; Zhang ZJ
    J Psychiatr Res; 2017 Feb; 85():59-65. PubMed ID: 27837658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological concerns in a trial of ziprasidone and olanzapine.
    Carnahan RM; Perry PJ
    Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
    Tybura P; Trześniowska-Drukała B; Bienkowski P; Beszlej A; Frydecka D; Mierzejewski P; Samochowiec A; Grzywacz A; Samochowiec J
    Psychiatry Res; 2014 Oct; 219(2):261-7. PubMed ID: 24930580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ziprasidone-augmentation of clozapine].
    Zink M; Mase E; Dressing H
    Psychiatr Prax; 2004 Jul; 31(5):259-61. PubMed ID: 15243877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
    Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU
    Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and mortality among hospitalized patients treated with intramuscular antipsychotics: analysis of a United States hospital database.
    Holdridge KC; Sorsaburu S; Houston JP; Saunders W
    Curr Drug Saf; 2010 Jul; 5(3):203-11. PubMed ID: 20210728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine as a possible replacement choice for paliperidone-induced Pisa syndrome: a case report.
    Tsou CC; Huang SY
    Australas Psychiatry; 2016 Dec; 24(6):545-547. PubMed ID: 27590078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.